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Abstract
BACKGROUND—Health care use and costs for children with spina bifida (SB) are significantly 
greater than those of unaffected children. Little is known about hospital use and costs across 
health insurance payer types. We examined hospitalizations and associated costs by 
sociodemographic characteristics and payer type during the first year of life among children with 
SB. We also examined changes in health insurance payer status.
METHODS—This study was a retrospective, statewide population-based analysis of infants with 
SB without anencephaly born in Florida during 1998–2007. Infants were identified by the Florida 
Birth Defects Registry and linked to hospital discharge records. Descriptive statistics on number 
of hospitalizations, length of stay, and estimated hospital costs per hospitalization and per infant 
were calculated during the first year of life. Results were stratified by selected sociodemographic 
variables and health insurance payer type.
RESULTS—Among 615 infants with SB, mean and median numbers of hospitalizations per 
infant were 2.4 and 2.0, respectively. Mean and median total days of hospitalization per infant 
were 25.2 and 14.0 days, respectively. Approximately 18% of infants were hospitalized more than 
three times. Among infants with multiple hospitalizations, 16.7% had a mix of public and private 
health insurance payers. Almost 60% of hospitalizations for infants were paid by public payer 
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sources. Mean and median estimated hospital costs per infant were $39,059 and $21,937, 
respectively.
CONCLUSIONS—Results suggest a small percentage of infants with SB have multiple 
hospitalizations with high costs. Further analysis on factors associated with length of stay, 
hospitalizations, and costs is warranted.
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INTRODUCTION
Spina bifida (SB) is a neural tube defect that results from a failure of the caudal neural tube 
to fuse early in embryonic development. The severity of impairment is related to the position 
of the defect along the spinal column and directly affects a child’s mobility and ability to 
maintain bowel and bladder control (Stevenson and Cate, 2005). In addition, the child is at 
risk for related comorbidities, such as hydrocephalus, seizures, scoliosis, skin ulcerations, 
and obesity (Simeonsson et al., 2002; Liptak and El Samra, 2010). A child with SB also 
might face challenges with educational, social, and psychological development (Stevenson 
and Cate, 2005).
After the 1998 implementation of mandatory folic acid fortification of the U.S. cereal grain 
supply, the occurrence of neural tube defects has notably declined (Honein et al., 2001; 
Williams et al., 2002; Canfield et al., 2005; Williams et al., 2005, Boulet et al., 2008). The 
most recent annual U.S. prevalence estimate for SB is approximately 1500 infants (Parker et 
al., 2010). In Florida, about 70 infants with SB were born each year between 1998 and 2007 
(Florida Department of Health, 2010).
Several studies have explored the health care economic burden of SB during childhood 
(Waitzman et al., 1996; Centers for Disease Control and Prevention, 2007; Grosse et al., 
2005; Russo and Elixhauser, 2007; Ouyang et al., 2007; Tilford et al., 2009; Cassell et al., 
2011) and in comparison to unaffected children (Waitzman et al., 1996; Centers for Disease 
Control and Prevention, 2007; Russo and Elixhauser, 2007; Ouyang et al., 2007; Cassell et 
al., 2011). Based on nationally weighted data from the Agency for Healthcare Research and 
Quality (AHRQ) Healthcare Cost and Utilization Project (HCUP) 2003 Kids’ Inpatient 
Database (KID), the mean hospital charges per neonatal admission for infants born with SB 
was $65,342 (Centers for Disease Control and Prevention, 2007). In comparison, the mean 
hospital charge per neonatal admission for uncomplicated births was much lower, $1844 
(Centers for Disease Control and Prevention, 2007).
Two recent studies explored health care expenditures for infants born with SB. Cassell et al. 
(2011) compared health care expenditures among North Carolina Medic-aid-enrolled 
children with SB with and without hydrocephalus for different age groups, including during 
the first year of life. The authors reported that infants born with SB who developed 
hydrocephalus had Medicaid health care expenditures 2.6 times higher than infants born 
with SB who did not develop hydrocephalus (Cassell et al., 2011). Using national private 
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health claims data, Ouyang et al. (2007) examined medical and prescription expenditures 
and found that individuals born with SB incurred the highest average total expenditures 
during their first year of life. Previous research on this topic suggests that the severity and 
health care costs of this birth defect continue to make it an important public health problem.
Despite these estimates of the health care economic burden associated with SB, gaps remain 
in our understanding. To our knowledge, no study has examined hospitalizations, length of 
stay, associated costs by health insurance payer type, and by selected demographic 
characteristics for infants with birth defects, including SB. Our aim was to describe hospital 
use, costs, and payer type in the first year of life for children born with SB, using data from 
a statewide, population-based birth defects registry linked to a statewide hospital discharge 
database.
METHODS
This study was a retrospective, statewide, population-based analysis of hospital use and 
costs of infants with SB born in Florida between January 1, 1998, and December 31, 2007. 
Data for this study were obtained from the Florida Department of Health Vital Statistics, the 
Florida Birth Defects Registry (FBDR), and the Florida Agency for Health Care 
Administration (AHCA).
The FBDR is a statewide, population-based surveillance system that uses passive case-
finding techniques to identify infants with birth defects during the first year of life (Florida 
Department of Health, 2010). The FBDR includes live-born infants whose mothers were 
residents of Florida at the time of the infant’s birth. The FBDR excludes infants who were 
adopted and whose mothers delivered out-of-state (Florida Department of Health, 2010). 
The Florida Department of Health Vital Statistics provides official birth and death records, 
which are linked to the FBDR. Infants with SB without anencephaly were identified by the 
FBDR, using the International Classification of Disease, 9th revision; Clinical Modification 
(ICD-9-CM) codes 741.00–741.9.
The statewide AHCA oversees Florida’s Medicaid program and the licensure of the state’s 
41,000 health care facilities (Agency for Health Care Administration, 2011). The AHCA 
data include information on inpatient and outpatient hospital use and charges for all 
registered Florida hospitals, birth centers, and surgical centers in the state (AHCA, 2011). 
Hospitalizations initiated during the first year of life, including birth hospitalizations and 
post-birth hospitalizations, were considered in the analysis. To allow for one year of 
hospitalizations for each infant with SB, AHCA data from 1998 through 2008 were linked to 
the FBDR.
Health care utilization variables were obtained from the AHCA data and included the 
number of hospital admissions, total inpatient charges, length of stay, and principal payer 
type for each hospitalization and per child. A hospitalization was defined as a single episode 
of hospital care, whether or not the hospital admission included an accompanying hospital 
transfer (Colvin and Bower, 2009). If hospital discharge records showed that an infant was 
admitted to a hospital on the same day the infant was discharged from another hospital, the 
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two admissions were merged into one hospitalization. If a one-day difference existed 
between a discharge from one hospital and an admission to another hospital and the records 
included a “transfer” code, the two admissions were also merged into one hospitalization.
The health insurance principal payer type was obtained from the AHCA hospital discharge 
records and was reported by three categories: 1) public, including Medicare, Medicaid, 
KidCare (Florida’s state children’s health insurance program), and Veterans benefits; 2) 
private or employer-based insurance, including military coverage (CHAMPUS/TriCare); 
and 3) self-pay, no insurance, or under-insured. The self-pay, no insurance, or under-insured 
category was defined as either no third party coverage or <30% estimated insurance 
coverage.
Total inpatient charges were adjusted to 2011 dollars using hospital industry data from the 
Producer Price Index (United States Department of Labor, 2011). Total inpatient charges 
were also converted to total estimated hospital costs, using the 2009 average all-payer 
inpatient hospital cost-to-charge ratio for the state of Florida, provided by the AHRQ. The 
most current average all-payer inpatient hospital cost-to-charge ratio, based on the average 
of 217 reporting Florida hospitals in 2009, was 0.281 (Agency for Healthcare Research and 
Quality: Health Care Utilization Project, 2009).
Descriptive statistics on the number of hospitalizations, length of stay, and estimated 
hospital costs were calculated for all hospitalizations initiated in the first year of life, but not 
necessarily completed during infancy. These results were further stratified by birth 
hospitalization and post-birth hospitalizations. Hospital resource utilization results were 
stratified by selected demographic variables and by principal health insurance payer type. 
Changes in principal payer type during the first year of life also were assessed.
For the bivariate analyses, we used chi-square tests to examine crude associations between 
selected demographic variables and number of hospitalizations, lengths of stay, and 
estimated total inpatient costs. Average length of stay was divided into four categories: <7 
days, 7–14 days, 15–28 days, and >28 days. Number of hospitalizations was divided into 
three categories: 1, 2–3, and ≥4 hospitalizations. Average total estimated costs were divided 
into three categories: <$10,000, $10,000–$25,000, and >$25,000.
All analyses were conducted using SAS software, version 9.2 (SAS, Cary, NC). This study 
received institutional review board approvals from the University of North Carolina at 
Charlotte, the Florida Department of Health, and the University of South Florida.
RESULTS
The FBDR identified a total of 669 infants with SB without anencephaly. Infants with SB 
included both isolated (SB ICD-9-CM code only) and multiple defects (SB and another 
major birth defect). Infants with SB were born live between 1998 and 2007. Of the 669 
infants, we were unable to link inpatient hospital discharge data for 54 infants. The final 
sample size for analysis was 615 infants with SB without anencephaly and included infants 
who died.
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Characteristics of Mothers and of Infants Born with SB
Of 615 infants with SB, 52.5% of mothers were non-Hispanic white, 24.9% were Hispanic, 
and 21.0% were non-Hispanic black. Mean maternal age was 27.5 years old (data not 
shown), and 41.6% of mothers had at least some college education. In addition, 51.7% of 
infants were female, 26.5% were born preterm (<37 weeks gestation), and 19.9% were born 
low birth weight (<2500 grams). About 7% (n = 41) of infants with SB died in the first year 
of life. Among these, 13 infants died in the first week of life (2.1% of the entire study 
sample). Of the 615 infants with SB, 74.8% (n = 460) of infants had an ICD-9-CM code of 
only SB; that is, there were no additional birth defects ICD-9-CM codes present (Table 1).
Number of Hospitalizations, Length of Stay, and Total Estimated Hospital Costs per Infant 
and by Principal Payer Type
Approximately 38% of infants with SB had only one hospitalization during the first year of 
life (Table 1). Mean and median number of hospitalizations per infant was 2.4 and 2.0, 
respectively. Mean and median total days of hospitalization per infant were 25.2 and 14.0 
days, respectively. Mean and median total estimated hospital costs per infant were $39,059 
and $21,937, respectively (Table 2). These types of results were expected because of the 
infants’ complex medical needs at this age.
Among the 615 infants, 49.9% had a public payer source for all hospital admissions, 38.4% 
had a private payer source for all hospital admissions, and 1.3% were self-pay, underinsured, 
or had no insurance. The remainder (10.4%) had multiple principal payer sources during 
infancy. When stratified by birth versus post-birth hospitalizations, 48.8% of infants with 
birth hospitalizations and 51.0% of infants with post-birth hospitalizations were covered by 
public payer sources alone. About 39% of infants with a birth hospitalization and 35.2% of 
infants with post-birth hospitalizations had private insurance as a principal payer without 
another payer source (Table 3).
Among infants with only public payer sources for first-year hospitalizations, mean and 
median lengths of stay for the birth hospitalization were 19.5 and 11.5 days, respectively, 
and 15.4 and 6.0 days for post-birth hospitalizations, respectively. For infants with only 
private insurance coverage during first-year hospitalizations, mean and median lengths of 
stay were 14.0 and 8.0 days, respectively, and 10.4 and 4.0 days, respectively, for post-birth 
hospitalizations. Infants with mixed payer types over their first-year hospitalizations had 
mean and median lengths of stay of 18.4 and 10.0 days for their birth hospitalizations and 
19.8 and 7.0 days for post-birth hospitalizations, respectively (Table 3).
Among infants with only a public principal payer, estimated mean and median estimated 
hospital costs for the birth hospitalization were $25,770 and $17,884, respectively. 
Estimated mean and median costs for post-birth hospitalizations among infants with only 
public payers were $24,880 and $9108, respectively. Among infants with only private 
payers, estimated mean and median hospital costs for the birth hospitalization were $22,072 
and $12,762, respectively, and mean and median post-birth costs were $18,024 and $8836, 
respectively. Infants with mixed payer types had estimated mean and median birth 
hospitalization costs of $31,005 and $19,656, respectively. For post-birth hospitalizations, 
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infants with mixed payer types had estimated mean and median costs of $38,348 and 
$11,820, respectively (Table 3).
Among infants who had multiple hospital admissions (n = 383), 16.7% (n = 64) had a mix of 
payer types during the first year of life (e.g., changed from a public to private payer source). 
Twice as many infants changed from a private to a public payer over the course of their first-
year hospital admissions (n = 20) compared with infants that changed from a public to a 
private payer (n = 9) (data not shown).
Hospitalizations, Length of Stay, and Total Estimated Hospital Costs per Hospitalization by 
Principal Payer Type
Among all hospitalizations during the first year of life for infants with SB (n = 1456 
hospitalizations), 58.3% were covered by public insurance, 39.4% were covered by private 
or employer-based insurance, and 2.2% of admissions were self-pay, were underinsured, or 
had no insurance (Table 4).
Mean and median lengths of stay per hospitalization across all principal payer types were 
10.7 and 4.0 days, respectively. For hospitalizations covered by self-pay, or were under-
insured or had no insurance, mean and median lengths of stay were 13.2 days and 6.0 days, 
respectively. For hospitalizations covered by public insurance, mean and median lengths of 
stay were 11.2 and 5.0 days, respectively. In comparison, for hospitalizations covered by 
private insurance coverage, mean and median lengths of stay were 9.7 days and 4.0 days, 
respectively (Table 4).
Mean and median total estimated hospital costs per hospitalization across all payer sources 
were $16,498 and $7002, respectively, adjusted to 2011 dollars (Table 4). When stratified by 
principal payer type, mean and median total estimated hospital costs for publicly funded 
hospital admissions were $16,537 and $7218, respectively. Mean and median total estimated 
hospital costs for privately funded hospital admissions were $16,245 and $6789, 
respectively (Table 4).
When stratified by principal payer type and by birth versus post-birth hospitalizations per 
hospitalization, mean and median total estimated hospital costs for publicly funded hospital 
admissions were $25,424 and $18,212, respectively, for birth hospitalizations and $11,854 
and $5376, respectively, for post-birth hospitalizations. Mean length of stay for publicly 
funded admissions was 19.0 days for birth hospitalization, with a median length of stay of 
11.0 days, and 7.1 days for post-birth hospitalizations, with a median length of stay of 3.0 
days. For privately funded hospital admissions, mean and median total estimated hospital 
costs were $24,170 and $12,978, respectively, for birth hospitalizations, and $10,000 and 
$5585, respectively, for post-birth hospitalizations. In contrast, for privately funded 
admissions, mean length of stay was 14.9 days for birth hospitalization with a median of 8.0 
days, and mean length of stay of 5.5 days for post-birth hospitalizations with a median of 3.0 
days (Table 4).
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Associations Between Maternal and Infant Characteristics and Total Estimated Hospital 
Costs, Length of Stay, and Number of Hospitalizations
There were statistically significant differences in total estimated hospital costs stratified by 
maternal age, maternal education level, and maternal marital status (Table 5). Among infants 
born to mothers under the age of 20, 50.9% had total estimated costs of more than $25,000, 
and 50.3% of infants born to mothers between the ages of 20 and 24 years had total 
estimated costs of more than $25,000. In comparison, 42.4% of infants born to mothers 
between 25 and 29 years had estimated total hospital costs of more than $25,000 and only 
36.4% of infants born to mothers between 30 and 34 years had estimated total hospital costs 
of more than $25,000. Fifty-one percent of infants born to unmarried mothers had total 
estimated hospital costs of more than $25,000, compared to 39.7% of infants born to married 
mothers (Table 5).
There were also significant differences between mean length of hospital stay and maternal 
race/ethnicity, preterm birth, and infants born with low birth weight, as well as between 
number of hospital admissions and infants born with low birth weight (Table 5). Over 18% 
of infants whose mothers were non-Hispanic black experienced average length of stay per 
hospital admission of >28 days compared to 7.4% of infants whose mothers were non-
Hispanic white and 5.2% of infants whose mothers were Hispanic (Table 5). No statistically 
significant differences were observed for number of hospitalizations and maternal race/
ethnicity, maternal age and marital status, maternal education, infant sex, and infants born 
preterm.
DISCUSSION
This study provided state-wide, population-based information on total estimated hospital 
costs and hospitalizations for hospitalizations initiated, but not necessarily completed during 
the first year of life, for infants born with SB in Florida. Total mean and median estimated 
hospital costs per infant were $39,059 and $21,937, respectively. We found the mean length 
of stay for birth hospitalizations, 17.1 day (across all payer types), was slightly higher than 
the 15.1 day previously reported using AHRQ HCUP 2003 KID data (Centers for Disease 
Control and Prevention, 2007). The difference could reflect differences in ascertainment 
methods of infants with birth defects because the AHRQ HCUP KID (Agency for 
Healthcare Research and Quality, 2009) analysis did not ascertain infants with birth defects 
based on birth defects surveillance records.
In this study, children with SB were significantly more likely to have been born with low 
birth weight or preterm compared to all live-born infants in Florida born during the study 
period (Florida Department of Health, 2010), which is consistent with previous findings 
(Petrini et al., 2002; Honein et al., 2009; Purisch et al; 2008). Infants with SB born with low 
birth weight and preterm may have prolonged hospitalizations and secondary conditions, 
such as urinary tract infections and respiratory distress syndrome, which can result in higher 
hospital use and costs. The other selected demographics in our study were similar to the 
overall demographics of live-born infants and mothers in Florida during the study period, 
except we had a slightly lower percentage of Hispanic mothers in our study (about 5% 
lower). In addition, in our study, 50% of infants with SB had only a principal public payer 
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source for all hospitalizations during infancy. In comparison, about 43% of all births in 
Florida during the study period were paid by Medicaid, a public payer source (Florida 
Department of Health, 2010).
Our analysis reported length of stay by payer status. First, mean birth hospitalization length 
of stay was 21.6% shorter for privately funded hospital admissions (14.9 days) than for 
publicly funded admissions (19.0 days). Similarly, the length of stay for post-birth 
hospitalizations averaged 5.5 days for privately funded hospital admissions, 22.5% shorter 
than the average of 7.1 day for publicly funded hospital admissions. Infants with little or no 
insurance were intermediate but closer to the public payer group. The difference in mean 
length of stay between public and private payers could potentially reflect worse health status 
among children with SB with public coverage and also a tendency for children with greater 
health care needs to transition from private to public insurance. Comparing Tables 3 and 4, 
the 32 infants who had birth hospitalizations covered by private insurers but had mixed 
payers for infancy as a whole had a mean length of stay during the birth hospitalization of 
18.4 days, compared to 14.0 days for those who had only private coverage throughout 
infancy.
When evaluating hospital costs by payer type per infant across all first-year hospitalizations, 
the percent of infants who had only public payers for all hospitalizations increased between 
birth and post-birth hospitalizations from 48.8% to 51.0%, whereas hospitalizations covered 
by private payers decreased between birth and post-birth hospitalizations from 38.8% to 
35.2%. Some of this change may have resulted from private insurers reaching maximum 
coverage limits and may be an indirect indication of the severity of an infant’s condition. 
Infants with mixed payer types over their first year incurred higher costs for both birth and 
post-birth hospitalizations and had greater length of stay for post-birth hospitalizations than 
children with a single principal payer source. Total estimated hospital costs for the mixed 
payer group during infancy as a whole were higher by 103% (mean) or 71% (median) than 
for the privately insured group and by 60% (mean) or 34% (median) than for the publicly 
insured group. Of even greater importance, among those with single payers, both mean and 
median costs were about 28% higher for those with public insurance coverage than for those 
with private coverage. Further exploration of payer patterns over time and across 
hospitalizations is warranted.
It is well known that a small minority of patients consume disproportionate amounts of 
health care resources. That is true for the present study as well, with mean hospital costs and 
length of stay per infant ($39,059 and 25.2 days, respectively) greater than the medians 
($21,937 and 14.0 days, respectively). A future analysis that addresses specific 
comorbidities, similar to the Cassell et al. (2011) study that examined children with SB with 
and without hydrocephalus, may provide a more complete picture of the health care costs 
associated with SB during infancy and throughout childhood.
This study faced several limitations. Infants identified for this study were based on the 
passive surveillance methodologies for identifying infants with birth defects in the FBDR. 
Whereas widely used, passive surveillance of birth defects does not actively verify the birth 
defect diagnosis by review of medical records, hospital charts, or nursery logs. Passive 
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surveillance techniques may lead to under-reporting or miss-reporting of infants with birth 
defects or specific defect type. In addition, because this analysis used data from the FBDR, 
it is a state-specific study, which might limit generalizability.
The study of the health care economic burden associated with any medical condition is 
complex (Folland et al., 2010). Health care charges refer to the fees that a health care 
provider requests for performance of a particular health care service (Agency for Healthcare 
Research and Quality, 2009; National Institute of Health, 2010), whereas health care 
expenditures reflect actual dollars paid for health-related services, regardless of the charge, 
by an individual or by any public or private payer (Agency for Healthcare Research and 
Quality, 2009; National Institute of Health, 2010). Health care cost is a general term that 
reflects the dollar amount a health care provider incurs in the delivery of health services 
(National Institute of Health, 2010). Hospital charges are facility fees and usually do not 
include professional fees. Hospital charges are almost always higher than costs or 
expenditures.
While acknowledging these differences in charges, costs, and expenditures, we tried to 
mitigate the limitation of reporting charges by converting charges to estimated hospital costs 
based on Florida’s average hospital cost-to-charge ratio using the most recent cost-to-charge 
ratios from AHRQ HCUP (Agency for Healthcare Research and Quality, 2009).
Hospital cost estimates from this study cannot be directly compared with previous estimates 
for children with SB for several reasons. First, costs are not equivalent to charges or 
expenditures. Second, some previous studies used a single payer source, such as private 
health insurance or Medicaid, which can have different reimbursement rates for services. 
Third, some previous studies did not adjust costs for inflation and/or used different case 
ascertainment methods.
It is also important to recognize that total estimated hospital costs only represent one 
component of health care costs, and, therefore, this study did not capture the full health care 
costs associated with the care of SB during infancy. To better estimate the total cost of care 
for infants with SB, information on other cost components, such as outpatient costs and 
prescription drug costs, would be needed. Inclusion of indirect costs, such as the value of 
care provided by the family within the home or the value of lost parental work time, would 
also contribute to a more complete understanding of the financial burden of this condition.
Last, we must acknowledge that the principal payer source variable used in this analysis was 
the expected principal payer source. It is unknown whether or not this was the actual payer 
source used. Furthermore, we cannot rule out the possibility that some infants may have had 
dual payer sources.
The primary strength of this study was use of a large, diverse, statewide, population-based 
sample based on birth defects surveillance data. We also reported results by per hospital 
admission and per infant. This was a strength of this study because previous studies only 
reported one or the other because of inherent limitations of the data sources used. 
Additionally, we converted the total hospital charges to estimated costs using the AHRQ 
HCUP cost-to-charge ratio files, which are based on accounting reports from Centers for 
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Medicare and Medicaid Services (AHRQ HCUP, 2009). Multiplication of the hospital 
charge by the cost-to-charge ratio results in an estimated hospital cost for those charges 
(AHRQ HCUP, 2009) and is a useful tool for making comparisons across cost and charge 
data.
Another strength of this study was the inclusion of both public and private payer sources, 
which provided new information on hospitalization costs associated with multiple payer 
sources for a population of infants with SB. In addition, examination of payer status by 
length of stay, estimated costs, and number of hospitalizations added unique information not 
previously reported in the literature. Our findings reinforce the need to include information 
from multiple payer sources for analysis of health care costs for this population. This study 
also reports that hospitalization costs for infants with SB are considerably greater for those 
with public or mixed insurance coverage than for those with only private insurance 
coverage, a finding that warrants further study.
Opportunities for future research include further exploration of the types of payer changes 
that occur during infancy and childhood (e.g., a switch from public to private vs private to 
public vs a combination of these payer types). Maternal and infant characteristics associated 
with changes in payer type and the effects of change in payer type on health care resource 
utilization and health outcomes will also be important to explore.
This descriptive study provided estimates of health care resource utilization, including 
hospital use and costs and by payer type, for infants born with SB in Florida during 1998–
2007. These findings highlight the importance of considering payer type and comorbidities 
in future estimates of costs associated with SB. This information may be important to health 
services researchers as they continue to examine access to care for infants with SB and other 
birth defects.
In addition, this study demonstrated that hospital discharge data collected by birth defects 
surveillance programs may be used to analyze differences in costs and payer status by 
selected sociodemographic information. Health service researchers and other state birth 
defects surveillance programs may collaborate to conduct similar analyses and determine 
any patterns and differences in results. A more complete understanding of the patterns of 
hospital use and costs associated with SB and other birth defects can inform program 
planning and policy development, which may ultimately contribute to improved health care 
delivery, quality of care, and improved health outcomes for families, infants, and children 
born with these conditions.
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Table 1




    <20 59 9.6
    20–24 165 26.8
    25–29 165 26.8
    30–34 129 21.0
    ≥35 96 15.6
Race/ethnicity
    Non-Hispanic white 323 52.5
    Hispanic 153 24.9
    Non-Hispanic black 129 21.0
Marital status
    Married 368 59.8
    Not married 247 40.2
Education
    <High school diploma 138 22.4
    High school graduate 213 34.6
    At least some college 256 41.6
Infant characteristics
Sex
    Female 318 51.7
    Male 297 48.3
Preterm Birth (<37 weeks gestation)
    Yes 163 26.5
    No 449 73.0
Low birth weight (<2500 grams)
    Yes 122 19.9
    No 492 80.0
Presence of other birth defects
    Isolated (SB only) 460 74.8
    Multiple (SB and another birth defect) 155 25.2
Hospitalizations in first year of life
    1 hospitalization 232 37.7
    2–3 hospitalizations 275 44.7
    ≥4 hospitalizations 108 17.6
Deaths in infancy (≤365 days) 41 6.7
SB, spina bifida.
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